NEW YORK ( TheStreet) -- Par Pharmaceutical Companies (NYSE: PRX) hit a new 52-week high Wednesday as it is currently trading at $37.24, above its previous 52-week high of $37.20 with 111,734 shares traded as of 1:38 p.m. ET. Average volume has been 412,700 shares over the past 30 days. Par Pharmaceutical Companies has a market cap of $1.31 billion and is part of the health care sector and drugs industry. Shares are up 9.9% year to date as of the close of trading on Tuesday. Par Pharmaceutical Companies, Inc., through its subsidiary, Par Pharmaceutical, Inc. engages in developing, licensing, manufacturing, marketing, and distributing generic and branded drugs in the United States.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter